Herpes Zoster - 33 Studies Found Completed : Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies. : Herpes Zoster : 2016-02-16 : Biological: Herpes Zoster Vaccine GSK1437173A Intramuscular injection Completed : Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults : Herpes Zoster : 2010-03-04 : Biological: Herpes Zoster Vaccine GSK 1437173A Investigational vaccine (GSK 1437173A) administered intra Completed : Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster : Herpes Zoster : 2013-03-28 : Biological: Herpes Zoster vaccine (GSK1437173A) 2 doses administered intramuscularly in deltoid region o Completed : Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older : Herpes Zoster : 2012-12-13 : Biological: Herpes zoster vaccine GSK1437173A 2 doses administered intramuscularly (IM) in the deltoid r Active, not recruiting : Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers : Herpes Zoster : 2013-01-10 : Biological: Herpes zoster vaccine (GSK 1437173A) Completed : Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years : Herpes Zoster : 2008-12-04 : Biological: Herpes zoster vaccine GSK1437173A Completed : Consistency, Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults ≥ 50 Years of Age : Herpes Zoster : 2014-02-27 : Biological: Herpes Zoster vaccine (GSK 1437173A) 2 doses administered intramuscularly in deltoid region Completed : Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older : Herpes Zoster : 2010-07-15 : Biological: Herpes Zoster Vaccine GSK1437173A Active, not recruiting : Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier : Herpes Zoster : 2015-10-19 : Biological: GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) 2 doses administered by Completed : Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A : Herpes Zoster : 2012-05-31 : Biological: Herpes Zoster vaccine GSK1437173A <<< Previous | Next >>>
